ACE Inhibitor, Drug Exposure

Variable Name

rx_aceinhibitor

Created

2024-05-21

Last Modified

Thumbnail Image

Files

1 Download↓
rx_ace_inhibitor_no_iv.csv (3.85 MB)
↓

Tags

Level of Review

Data Model


Abstract

Concept set intended to identify patients with an ACE inhibitor medication exposure.

Affiliation(s)

Children's Hospital of Philadelphia

Funder(s)

Provenance

Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)

Description

This medication concept set includes the following ingredients: Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Periondopril, Quinapril,Ramipril, Trandolapril. It also includes combinations of these ingredients with other antihypertensive medications. This concept set, in contrast to its previous version, does NOT contain IV formulations.

This code list was generated by taking the descendants of all the ACE inhibitor ingredients of interest and string matching with the concept_name of the ingredient. The broad concept set was intended to identify patients who received ACE inhibitors. It is limited to NDC, RxNorm, and RxNorm Extension codes. Meds were expected to be only oral/enteral/IV, not topical, ophthalmic/ocular, or buccal.

Development Code

https://github.com/PRESERVE-Coordinating-Center/PRESERVE_Variables/blob/dfe52bdc48cfcfd6b358d4a424b5d39749554025/codesets/drug/rx_ace_inhibitor.csv

Vocabulary

Medication Classification Level










Clinical Subjects Headings

Data Source

Related Phenotype

Related Person

Related Study

Thumbnail Image
Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)
Children's Hospital of Philadelphia
Study intended to inform shared decision-making regarding blood pressure management for pediatric chronic kidney disease (CKD).

Related Concept Set

Related Code

Related Publications

Creative Commons license

a CC-BY Attribution 4.0 License.
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 License.


Version History

Now showing 1 - 2 of 2
VersionDateSummary
2*
 2024-09-24 13:30:28
This version does NOT contain IV formulations.
1
 2024-06-10 15:03:21
This version DOES contain IV formulations.
* Selected version